Hadeer Mohamed

Hadeer Mohamed

Auto-generated profile, based on publicly available information

Hadeer Mohamed

Oncology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 September 2017 in Journal of Evidence-Based Medicine
Verified
Journal Article
Closed access
PDF file
OAOmar Abdel-Rahman
Omar Abdel-Rahman
DHDaniel Helbling
Daniel Helbling
OSOthmar Schöb
Othmar Schöb
MEMostafa Eltobgy
Mostafa Eltobgy
HMHadeer Mohamed
Hadeer Mohamed
HOHani Oweira
Hani Oweira

30 August 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MAMuneer J. Al-Husseini
Muneer J. Al-Husseini
ASAnas M. Saad
Anas M. Saad
HMHadeer H. Mohamed
Hadeer H. Mohamed
MAMohamad A. Alkhayat
Mohamad A. Alkhayat
MSMohamad Sonbol
Mohamad Sonbol
OAOmar Abdel-Rahman
Omar Abdel-Rahman
Most clinical trials on colorectal cancer (CRC) exclude cases who have history of a prior malignancy. However, no prior research studied this history’s actual impact on the survival of CRC. In the paper, we study the effects of having a malignancy preceding CRC diagnosis on its survival outcomes. CRC patients diagnosed during 1973–2008 were reviewed using the SEER 18 database. We calculated overall survival and cancer-specific survival of subsequent CRC, and more specifically stage IV CRC, using Kaplan-Meier test and adjusted Cox models. A total 550,325 CRC patients were reviewed, of whom 31,663 had history of a prior malignancy. The most commonly reported sites of a prior malignancy were: prostate, breast, urinary bladder, lung, and endometrium. Patients with history of a prior non-leukemic malignancy or history of a prior leukemia were found to have worse overall survival (HR = 1.165 95%CI = 1.148–1.183, P < 0.001) and (HR = 1.825 95%CI = 1.691–1.970, P < 0.001), respectively. However, CRC patients with history of a prior non-leukemic malignancy showed an improved colorectal cancer-specific survival (HR = .930 95%CI = .909–.952, P < 0.001). Analysis of stage IV CRC patients showed that patients with history of any non-leukemic malignancy did not have a significant change in overall survival. Whereas, patients with a prior leukemia showed a worse overall survival (HR = 1.535, 95%CI = 1.303–1.809, P < 0.001). When analyzed separately, right CRC and left CRC showed similar survival patterns. A prior malignancy before CRC -in general- can be associated with worse clinical survival outcomes. These worse outcomes are not observed in stage IV CRC. Considering these results when including/excluding stage IV CRC patients with prior malignancies in clinical trials may play help improve their generalizability.

8 January 2018 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
OAOmar Abdel-Rahman
Omar Abdel-Rahman
ZEZeinab Elsayed
Zeinab Elsayed
HMHadeer Mohamed
Hadeer Mohamed
MEMostafa Eltobgy
Mostafa Eltobgy

14 April 2021 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
BSBasem Saleh
Basem Saleh
Mohamed A. ElhawaryMohamed A. Elhawary
Mohamed A. Elhawary
MMMoataz E. Mohamed
Moataz E. Mohamed
IAIslam N. Ali
Islam N. Ali
MZMenna S. El Zayat
Menna S. El Zayat
HMHadeer Mohamed
Hadeer Mohamed

3 September 2018 in Current Problems in Cancer
Verified
Journal Article
Closed access
MAMuneer J. Al-Husseini
Muneer J. Al-Husseini
HMHadeer H. Mohamed
Hadeer H. Mohamed
ASAnas M. Saad
Anas M. Saad
MGMohamed M. Gad
Mohamed M. Gad
MAMona Atia
Mona Atia
MEMohamed El-Shinawi
Mohamed El-Shinawi

18 March 2023 in Journal of Herbmed Pharmacology
Verified
Journal Article
Open access
PDF file
HMHadeer Saad Mohamed
Hadeer Saad Mohamed
TKTahany Kholief
Tahany Kholief
RMRadwa Wahid Mohamed
Radwa Wahid Mohamed
AEAmira Abd El-Rhman
Amira Abd El-Rhman
Introduction: Antioxidant and hypoglycemic properties of some plant seeds are considered natural preventives for diabetic-associated glycation. This study is concerned with the evaluation of the bioactive components of black chia and garden cress seeds and the examination of their modulatory effects on hyperglycemia and associated glycation induced by streptozotocin (STZ) injection. Methods: Forty male rats were divided into 4 groups, 10 rats each: Group 1 (healthy control group); group 2 (diabetic group): rats injected STZ intraperitoneally to induce hyperglycemia; group 3 and group 4: rats treated (after diabetic induction) with 1 mL (20% w/w) black chia and garden cress seed extract, respectively. Results: STZ injection caused marked hyperglycemia, oxidative stress, glycation, and inflammation condition with disturbance in organs functions and structural alterations in pancreatic tissue, while; treatment with black chia and garden cress seed extracts showed remarkable (P < 0.05) modulatory effects on hyperglycemia and associated disorders. Conclusion: Black chia and garden cress seeds might be used in the management of diabetes and associated glycation.